Vir Biotechnology Inc (VIR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -437,987 | -521,960 | -615,117 | 515,837 | 528,584 |
| Depreciation Amortization | 21,154 | 19,956 | 10,745 | -2,160 | 5,567 |
| Income taxes - deferred | N/A | N/A | N/A | -15,186 | 15,186 |
| Accounts receivable | N/A | N/A | N/A | 770,038 | -773,079 |
| Accounts payable and accrued liabilities | 4,997 | -988 | 732 | 797 | -171 |
| Other Working Capital | -22,447 | -83,322 | -332,709 | 665,367 | -628,394 |
| Other Operating Activity | 42,502 | 139,962 | 157,564 | -271,440 | 804,718 |
| Operating Cash Flow | $-391,781 | $-446,352 | $-778,785 | $1,663,253 | $-47,589 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 314,950 | 503,296 | 186,202 | -1,125,455 | -118,997 |
| PPE Investments | -4,579 | -3,929 | -21,573 | -68,006 | -21,817 |
| Investing Cash Flow | $310,371 | $499,367 | $164,629 | $-1,193,461 | $-140,814 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | -260 | -259 |
| Common Stock Issued | 4,146 | 4,553 | 7,767 | 36,218 | 100,590 |
| Other Financing Activity | -361 | -165 | -287 | -1,197 | 0 |
| Financing Cash Flow | $3,785 | $4,388 | $7,480 | $34,761 | $100,331 |
| Beginning Cash Position | 318,695 | 261,292 | 867,968 | 363,415 | 451,487 |
| End Cash Position | 241,070 | 318,695 | 261,292 | 867,968 | 363,415 |
| Net Cash Flow | $-77,625 | $57,403 | $-606,676 | $504,553 | $-88,072 |
| Free Cash Flow | |||||
| Operating Cash Flow | -391,781 | -446,352 | -778,785 | 1,663,253 | -47,589 |
| Capital Expenditure | -4,832 | -7,301 | -21,573 | -68,006 | -21,817 |
| Free Cash Flow | -396,613 | -453,653 | -800,358 | 1,595,247 | -69,406 |